Mutual Funds

UTI Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

341.32 -1.52
NAV(₹) as on 11/9/2026

-0.44%
1D

15.37%
1Y

22.89%
3Y

15.00%
5Y

UTI Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.2	Launch Date: 01 Aug 2005
Exit Load: 1% on or before 30D, Nil after 30D	AUM: ₹ 1,443.57 Crs
Lock-in: Nil	Investing Style: Mid Growth
Portfolio Price To Book Value: 7.69	Min. Investment: SIP : ₹ NA Lumpsum : ₹ 5,000.00
Scheme Benchmark: NA
Fund Manager: Kamal Gada

FUND OBJECTIVE

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 31/8/2026		5.73 %		94.27 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

8.25 %

Divi's Laboratories Ltd.

6.21 %

Ajanta Pharma Ltd.

4.74 %

Gland Pharma Ltd.

3.70 %

Dr. Reddy's Laboratories Ltd.

3.62 %

Alkem Laboratories Ltd.

3.29 %

Apollo Hospitals Enterprise Ltd.

3.27 %

Max Healthcare Institute Ltd.

3.10 %

Lupin Ltd.

3.09 %

Caplin Point Laboratories Ltd.

3.05 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

69.30 %

Hospital & Healthcare Servic

23.54 %

Medical Equipment/Supplies/A

0.98 %

Business Support

0.45 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2021-22	2022-23	2023-24	2024-25	2025-26
NAV (31/3/2026)	157.00	143.40	223.40	268.23	271.22
Net Assets (Rs Crores)	77,623.29	65,449.87	94,725.87	1,04,203.85	1,05,553.48
Scheme Returns(%)(Absolute)	12.06	-8.81	55.54	18.69	2.56
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	50/75	68/76	21/90	5/102	31/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 21.94 +-0.10	4/10/2023	₹ 3,310.64	26.04%	-	-	30.79%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.97 +-0.08	6/2/2024	₹ 902.24	20.61%	-	-	22.59%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 12.12 +-0.04	6/12/2024	₹ 125.15	22.42%	-	-	11.51%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.92 +-0.03	27/12/2024	₹ 405.91	20.12%	-	-	10.82%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.74 +-0.01	27/6/2025	₹ 507.42	9.44%	-	-	6.07%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.29 +-0.04	28/11/2025	₹ 331.57	-	-	-	12.85%
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.19 +-0.12	11/12/2023	₹ 767.7	26.06%	-	-	21.75%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 567.34 +-1.26	5/6/2004	₹ 9,479.08	9.73%	17.50%	12.61%	19.87%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 18.07 +-0.06	8/11/2021	₹ 276.23	9.86%	17.58%	-	13.00%
Tata India Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 33.19 +-0.18	28/12/2015	₹ 1,565.28	7.09%	17.92%	12.90%	11.85%